ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide"
Episode Synopsis
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
More episodes of the podcast Annals On Call Podcast
Palliative Care: A Family Perspective
17/11/2025
What You May Have Missed in 2024: Part 3
03/11/2025
What You May Have Missed in 2024 - Part 2
20/10/2025
What You May Have Missed in 2024: Part 1
15/09/2025
Diagnosing Primary Aldosteronism
14/07/2025
In God we trust